GEODE CAPITAL MANAGEMENT, LLC - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 60 filers reported holding OBALON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$79,000
-16.8%
113,067
+70.2%
0.00%
Q1 2019$95,000
-65.3%
66,444
-50.0%
0.00%
Q4 2018$274,000
+194.6%
132,888
+387.0%
0.00%
Q1 2018$93,000
-47.8%
27,287
+1.1%
0.00%
Q4 2017$178,000
-22.6%
27,001
+11.5%
0.00%
Q3 2017$230,000
+0.9%
24,220
+5.1%
0.00%
Q2 2017$228,000
+11.2%
23,055
+19.8%
0.00%
Q1 2017$205,000
+73.7%
19,252
+43.6%
0.00%
Q4 2016$118,00013,4090.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 3,552,239$9,591,0004.68%
Tamarack Advisers, LP 2,100,000$5,670,0001.62%
Moisand Fitzgerald Tamayo, LLC 6,765$302,0000.17%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$892,0000.10%
HoyleCohen, LLC 114,650$310,0000.06%
Granite Investment Partners, LLC 77,511$210,0000.01%
C WorldWide Group Holding A/S 315,504$852,0000.01%
Cerity Partners LLC 20,686$56,0000.00%
Spark Investment Management LLC 18,300$49,0000.00%
HighTower Advisors, LLC 126,288$342,0000.00%
View complete list of OBALON THERAPEUTICS INC shareholders